complexes, leads to myocardial disorders, but the neuronal phenotype is unknown (Yoshida et al., 1996) . Recently, however, it has been reported that knockout mice for either the ␣ subunit of the CNTFR (DeChiara et al., 1995) or the ␤ subunit of the transmembrane LIFR (common to both receptor complexes) (Li et al., 1995b ) die shortly after birth. In contrast with null mutants for the corresponding factors, both receptor mutants show a loss of approximately 40% of motoneurons in spinal cord and brain stem. These results suggest that an unidentified ligand of the CNTFR and/or LIFR plays a physiological role in regulating motoneuron survival in vivo. Recently, a novel member of the IL-6 family of cytokines, called cardiotrophin-1 (CT-1), was identified and cloned based on its ability to induce hypertrophy in cultured neonatal cardiac myocytes (Pennica et al., 1995a) . In the presence of gp130, CT-1 binds to the LIFR␤ subunit with an affinity in the nanomolar range, in a competitive manner with LIF (Pennica et al., 1995b) . Like CNTF, CT-1 has no signal peptide but is secreted by transfected cells in vitro (Pennica et al., 1995a) . In addition to its hypertrophic activity, it also enhances survival and maturation of different neuronal populations in culture (Pennica et al., 1995b) . Here, we show that CT-1 can provide long-term support to a fraction of motoneurons very similar to that lost in the CNTFR and LIFR knockout mice and that its expression pattern is consistent with a role as a target-derived neurotrophic factor during normal motoneuron development.
Results

Cardiotrophin-1 mRNA Is Present in the Environment of the Embryonic Motoneuron
To determine whether cardiotrophin-1 might be available to developing motoneurons, CT-1 mRNA expression was analyzed by in situ hybridization during the period of motoneuron cell death. At embryonic day 13.5 (E13.5) in the mouse, the stage at which motoneuron death is about to begin, there was a strong signal for the limb bud by in situ hybridization (data not shown).
In parallel experiments using a probe for mouse LIF, no specific signal was detected at either E13.5 or PN1 (data ure 1C), the amplified fragment (281 bp) hybridized to a specific internal oligonucleotide (data not shown). A not shown).
We used semiquantitative reverse transcriptasestrong CT-1 signal was obtained using E14.5 limb bud ( Figure 1C ). However, in agreement with our results from polymerase chain reaction (RT-PCR) to compare levels of CT-1 in limb bud at the beginning and the end of the in situ hybridization, levels of CT-1 mRNA were markedly reduced by the end of cell death ( Figure 1C ). the motoneuron cell death period. Samples of cDNA prepared from total limb bud of E14.5 mouse embryos These results suggest that CT-1 may be available to motoneurons at high levels as competition for muscleand PN1 mouse pups were normalized for GAPDH mRNA ( Figure 1C ). When RT-PCR was performed on derived trophic support begins, and that subsequently only lower levels of this factor may be present. the same samples using primers specific for CT-1 (Fig-Figure 2 . Muscle Cells Express mRNA for CT-1 and Secrete Mature CT-1 Protein (A) Total RNA from the indicated cells was reverse transcribed and amplified using specific primer pairs for mouse CT-1. All muscle cells expressed high levels of CT-1 mRNA, whereas neither C6 glioma nor purified motoneurons had detectable levels. A plus or minus sign indicates with or without reverse transcriptase, respectively. (B) Western blots of recombinant mouse CT-1 (CT-1), complete culture medium (CCM), and medium conditioned by C2/C7 myotubes (C2/C7) stained using an affinity-purified antibody to CT-1. Specific immunoreactivity was only observed at an apparent molecular mass of 30 kDa. Using the possibilities for long-term analysis provided by Neurobasal medium, we cultured motoneurons in the Using affinity-purified rabbit polyclonal antibodies to muCT-1, we detected a band at 30 kDa in medium condipresence and absence of CT-1 for periods up to 16 days in vitro. Even at low density, motoneurons survived and tioned by C2/C7 myotubes, but not in unconditioned medium ( Figure 2B) . By comparing the intensity of the matured in these conditions to a remarkable degree. In the presence of CT-1, motoneurons developed rapidly band on the Western blot with that obtained using different quantities of recombinant CT-1 (data not shown), in culture and after 3 days had developed long axons and multipolar morphology ( Figure 4A ). After longer periwe estimate that myotube-conditioned medium contains approximately 1-5 ng/ml CT-1. Thus, CT-1 is seods in the presence of CT-1, morphological development of motoneurons was even more pronounced. At creted at biologically significant levels by healthy differentiated myotubes in culture.
Cardiotrophin-1 Is
9-11 days of culture, surviving neurons showed a highly Despite the obviously healthy appearance of surviving motoneurons, optimal concentrations of CT-1 were not capable of maintaining all motoneurons in the long term. In six independent experiments counted between 9 days and 16 days of culture, the fraction of motoneurons surviving in the presence of CT-1 was 43% Ϯ 1%. The corresponding value for cultures without trophic factor was 6% Ϯ 2% (n ϭ 6). In the same experiments, GDNF, the most potent survival factor for motoneurons in shortterm culture (Henderson et al., 1994) , maintained only 24% Ϯ 6% (n ϭ 6) of motoneurons that initially developed in culture. The number of surviving motoneurons was not increased when different concentrations of CT-1 or GDNF, or different regimens for medium replenishment, were tested (data not shown). These values therefore seem to represent characteristic fractions of We compared the capacity of three cytokines of the IL-6 subfamily, CT-1, CNTF, and LIF, to support longterm survival. In 14 experiments in which identical concentrations (10 or 100 ng/ml, depending on the experiment) of mouse CT-1, rat CNTF, or mouse LIF were assayed in parallel, the numbers of motoneurons kept alive by each factor, expressed relative to CT-1, were 100% (CT-1), 93% Ϯ 6% (CNTF), and 80% Ϯ 6% (LIF). When optimal concentrations of different pairs of cytokines were assayed in combination, the number of surviving motoneurons did not increase (data not shown). Therefore, many of the same motoneurons that respond to CT-1 are also kept alive in culture by CNTF or LIF.
Our in vitro results therefore suggest that a characteristic fraction ‫)%54ف(‬ of motoneurons survive and mature in the presence of cytokines, in particular the musclederived cytokine CT-1. Interestingly, CT-1 alone is 80% more efficacious than GDNF in this system. be tested was applied directly to the nerve stump; 1, 2, and 3 weeks later, the rats were sacrificed, and the in vivo, raised the possibility that CT-1 might be a physiosurviving fluorescently labeled motoneurons were logical survival factor for embryonic motoneurons. Two counted on the operated side. cytokine receptor subunits, LIFR␤ and CNTFR␣, were The initial number of sciatic motoneurons in the newrecently shown to be essential for the survival of motoborn rat was determined by applying Fluorogold alone neurons in knockout mice (DeChiara et al., 1995; Li et to the cut sciatic nerve and sacrificing the rats 60-70 al., 1995b). We therefore designed experiments to test hr later; the value thus obtained was 1385 Ϯ 150 (n ϭ the hypothesis that CT-1 might be the physiological 4). A majority of these motoneurons had died by 1 week ligand for these receptors. after axotomy: only 449 Ϯ 74 (n ϭ 5) motoneurons were One characteristic property of the CNTFR complex is maintained in vehicle-treated animals, indicating that the presence of the GPI-linked CNTFR␣ subunit. As a approximately 936 cells had degenerated. first step toward testing the possibility that CT-1 might When animals were treated with CT-1 at 0.7 mg/ml, the act through the CNTFR complex, we tested the capacnumber of motoneurons determined at 1 week (884 Ϯ ity of phosphatidylinositol-specific phospholipase C 47, n ϭ 6) was significantly greater than in controls.
CT-1 Protects Motoneurons against the
(PIPLC) to inhibit the CT-1 survival response. PIPLC can Therefore, application of CT-1 can rescue about 46% specifically cleave the GPI linkage that attaches certain of the cells that would normally have died during this molecules to the surface of living cells (Low et al., 1986). period. The short-term rescue effects of CT-1 were very Purified motoneurons in suspension were treated in similar to those of LIF at this same concentration (883 Ϯ complete culture medium for 2 hr at 37ЊC with 1-2 g/ml 164, n ϭ 3). Furthermore, the efficacy of CT-1 was not PIPLC (or an equivalent volume of phosphate-buffered significantly changed when applied at 0.3, 0.7, or 1.5 saline [PBS]) before being seeded in 16 mm wells in the mg/ml. presence or absence of different trophic factors. PIPLC As with all other neurotrophic factors tested using this was replaced in appropriate wells at 1-2 g/ml at 0 hr protocol (Vejsada et al., 1995) , protection afforded by and 14 hr of culture; motoneuron survival was quantified a single dose of CT-1 decreased with time ( Figure 5) . after 24-48 hr ( Figures 6A and 6B ). As expected, motoNonetheless, a supramaximal dose of 1.5 mg/ml caused neuron survival in basal medium or in the presence of a significant rescue of motoneurons above the control 1 ng/ml BDNF, which acts through the transmembrane levels at 1, 2, and 3 weeks. These long-term partial TrkB receptor, did not differ significantly between survival effects obtained with CT-1 have never been PIPLC-treated and control motoneurons (in six indepenobserved with CNTF or LIF (Vejsada et al., 1995) . dent experiments, the mean number of PIPLC-treated motoneurons that survived in 1 ng/ml BDNF was 107% Ϯ 6% of the number of untreated motoneurons). PIPLC is The CT-1 Receptor on Motoneurons Has a GPI-Linked Component not therefore toxic for motoneurons at this concentration (similar results were obtained using 5 g/ml PIPLC; The secretion of CT-1 by embryonic muscle, and its potent neurotrophic activity on motoneurons in vitro and data not shown). Subsequently, the survival response in the presence expression cloning: both LIF and CT-1 induce myocyte hypertrophy, whereas CNTF has little or no activity (Penof different cytokines was tested ( Figure 6A ). The numnica et al., 1995a). This difference in activity is presumber of motoneurons surviving in 10 ng/ml LIF remained ably due to the lack of expression of CNTFR␣ on myounchanged after treatment with 1 g/ml PIPLC, whereas cytes. When CNTF was added to cardiac myocytes the response to 10 ng/ml CNTF was decreased as exalone, no hypertrophy was observed. However, when pected. Strikingly, the response to 10 ng/ml CT-1 was the same concentration of CNTF was added in the presreduced to the same extent ( Figure 6A ). In subsequent ence of 25 nM or 50 nM sCNTFR, then hypertrophy was experiments, PIPLC was used at 2 g/ml: even greater close to maximal (scores 6.0 and 6.5, respectively) and reductions in CNTF-and CT-1-dependent survival were similar to that reported for LIF and CT-1 ( Figure 7A ). observed, even when cytokines were applied at 50 ng/ Thus, the purified sCNTFR was biologically active and ml ( Figure 6B ). On average (n ϭ 3), the ratios of the allowed CNTF to signal through the LIFR complex as numbers of surviving motoneurons in the presence and previously described (Davis et al., 1993). absence of 2 g/ml PIPLC were 112% Ϯ 23% (LIF),
We first tested the ability of CT-1 to bind directly to 20% Ϯ 3% (CNTF), and 23% Ϯ 8% (CT-1).
sCNTFR␣. 125 I-labeled CT-1 (0.7 nM) was incubated with These data show that a GPI-linked component is resCNTFR␣ (40 nM) for 2 hr at room temperature, and any quired for CT-1 action in this system. This component complexes formed were captured using nickel agarose may contribute to the CT-1 receptor complex in a manbeads. No specific binding could be detected (data not ner analogous to that of the CNTFR␣ to the CNTFR shown). Using an identical protocol, strong specific complex. The incomplete loss of CT-1 sensitivity in binding of labeled CT-1 to sLIFR, and of labeled CNTF to PIPLC-treated motoneurons may reflect incomplete acsCNTFR␣, were observed as expected, demonstrating cess of PIPLC to the GPI linkage, as suggested by the that all components were functional (data not shown). greater effect observed using 2 g/ml PIPLC (Figures To exclude the possibility that CT-1 bound to sCNTFR␣ 6A and 6B), or action of CT-1 through the residual LIFR might be lost during precipitation of the complex, we still present on these cells (Pennica et al., 1995b) . performed incubations of labeled CT-1 with sCNTFR␣ or sLIFR in the same conditions, except that after 2 hr CT-1 Is Not a Ligand for the CNTFR␣ Subunit the cross-linker 1-ethyl-3-(3-dimethylaminopropyl) carSince CT-1 is related to CNTF, an obvious candidate for bodiimide/N-hydroxysulfosuccinimide (EDC/sulfo-NHS) the putative GPI-linked component revealed by PIPLC was added for 30 min. After analysis by SDS-PAGE, no treatment was the CNTFR␣ subunit, the GPI-linked subcross-linking of CT-1 to sCNTFR␣ could be detected, unit that is necessary for signaling through the gp130/ whereas CT-1 and sLIFR gave a radioactive cross-linked LIFR complex. We therefore directly examined, by sevproduct of the appropriate size that disappeared when eral methods, the ability of CT-1 to bind this subunit.
the incubation was performed in the presence of 1 M A soluble form of the rat CNTFR (sCNTFR) was exunlabeled CT-1, but remained in the presence of 1 M pressed as its extracellular domain containing a carunlabeled CNTF (data not shown). boxy-terminal histidine tag and purified by chelate chroSince we could detect no direct binding of CT-1 to matography (see Experimental Procedures). To confirm sCNTFR␣, we used functional assays to detect possible that the recombinant sCNTFR␣ was biologically active, interactions between them. First, the hypertrophy of carwe assessed its ability to cause hypertrophy of neonatal diac myocytes was assayed in the presence of different cardiac myocytes in the presence of its ligand. This CT-1 concentrations ranging from 1 pM (no hypertrophy) to 200 pM (near-maximal hypertrophy). No change in hypertrophy assay was originally used to isolate CT-1 by any of the hypertrophy scores was observed when the same CT-1 concentrations were tested in the presence of biologically active concentrations of sCNTFR␣ ( Figure  7B) . Thus, the hypertrophy response of the myocytes to CT-1 is not potentiated by sCNTFR␣.
A further demonstration of the inability of sCNTFR␣ to facilitate CT-1 action was provided by analysis of purified motoneurons treated with PIPLC. As described above, PIPLC-treated motoneurons responded only poorly to 50 ng/ml CNTF ( Figure 7C ). However, in the presence of 25 nM sCNTFR␣, the CNTF response of PIPLC-treated motoneurons was completely reconstituted. In contrast, sCNTFR␣ caused no increase in the response of PIPLC-treated motoneurons to CT-1, although motoneurons treated with PIPLC and CT-1 were still capable of a normal response to LIF ( Figure 7C ). sCNTFR␣ itself had no effect on the response to LIF ( Figure 7C) . Therefore, even in the specific environment of the motoneuron membrane, sCNTFR␣ cannot mediate interactions of CT-1 with the LIFR complex.
It remained possible that CT-1 exerted its biological effects through CNTFR␣, but was unable to interact functionally with the soluble form of the receptor. We therefore tested the ability of CT-1 to compete for the binding of radiolabeled CNTF to the rat adrenal pheochromocytoma PC12 cell line ( Figure 8A Taken together, these data suggest that CT-1 is not a ligand for the CNTFR␣ subunit. The GPI-linked component of the CT-1 receptor complex on motoneurons may therefore be a novel cytokine receptor subunit.
Discussion
Our results make cardiotrophin-1 a strong candidate as a physiological motoneuron survival factor. It supports Figures 7 and 8) . ble that the same motoneurons are lost in each mutant.
Although prudence is required in comparing in vivo and
Although we cannot completely rule out the possibility that CT-1 can act through CNTFR␣ in the specific enviin vitro data, it is striking that the percentages of motoneurons that survive in the presence of CT-1 in our longronment of the motoneuron membrane, the simplest hypothesis would be that CT-1 action requires a novel term cultures (43%) and in vivo after axotomy (46%) are very similar to the fraction lost in CNTFR and LIFR GPI-linked ␣ subunit. Our tentative conclusion, therefore, is that the cytokine whose existence is implied by knockout mice. Moreover, in short-term cultures of motoneurons, CNTF has been reported to support approximotoneuron loss in the CNTFR knockout mice is not CT-1. Interestingly, binding of CT-1 to non-neuronal mately half of the total population (Arakawa et al., 1990; Martinou et al., 1992; Henderson et al., 1994) . In all these cells expressing LIFR is not PIPLC-sensitive, and PIPLC treatment did not reduce the ability of CT-1 to induce experimental systems, motoneuron death is continuing (at least at a reduced rate) at the time at which survival cardiac myocyte hypertrophy. These data suggest that the novel GPI-linked component may not be present on is estimated. It would therefore be inappropriate to attribute too great a significance to the absolute value of all CT-1-responsive cell types. Further analysis of the physiological role of CT-1 in the spinal cord will involve 45%. Nevertheless, the data are consistent with the idea that a discrete subpopulation of motoneurons is capable identification of the GPI-linked component, as well as inactivation of the CT-1 gene itself. of responding to cytokines and requires them for survival. Most motoneurons in this population must express Consistent with a role in regulating motoneuron numbers during development, levels of CT-1 mRNA are high both CNTFR␣ and LIFR␤ subunits since, using E14 rat motoneurons, optimal concentrations of CNTF gave in limb bud at the beginning of cell death and subsequently fall off steeply (Figure 1) . Similar developmental similar long-term survival values to LIF, and combinations of different cytokines did not further increase surregulation was reported for levels of LIF mRNA, which fall rapidly between E17 and birth in mouse hind leg vival. It is not known whether only a fraction of motoneurons in situ express different components of the cytokine muscles (Kwon et al., 1995) . Using an antiserum to CT-1, Sheng et al. (1996) recently described high levels of CT-1 receptor complex. It will thus be important to determine whether cytokine-responsive motoneurons differ from protein at E15.5 in skeletal muscle, the target tissue of motoneurons, but did not compare levels at later stages. other motoneurons in this respect, or in terms of other markers involved in signaling and survival.
The presence of CT-1 mRNA in adult skeletal muscle -nitrilo-triacetic of culture and subsequently omitted. Subsequently, every 4-5 days, acid-agarose (QIAGEN) as described (Pennica et al., 1995a). 1.5 ml of medium was removed and replaced with 1.5 ml fresh medium containing sufficient quantities of the indicated neuroMyocyte Hypertrophy Assay trophic factor to supplement the 2 ml of medium in the dish. For Substances were tested as described previously (Pennica et al., longer term cultures, precautions were taken to maintain high hu1995a). In brief, hearts were excised from 1-day-old Spraguemidity, so as to prevent concentration of medium components by Dawley rats. Ventricular cardiac myocytes were isolated by collaevaporation.
genase digestion and Percoll gradient purification. The myocytes were diluted into serum-free DMEM/F12 supplemented with 10 g/ Quantification of Motoneuron Survival in Culture ml transferrin, 1 g/ml insulin, 1 g/ml aprotinin, 2 mM glutamine, Motoneuron survival was quantified by direct counting under phase-100 U/ml penicillin G, and 100 g/ml streptomycin and plated at a contrast in a predetermined area of 1. 
